Abstract | AIM: To investigate the use of thermosensitive magnetoliposomes (TMs) loaded with magnetic iron oxide (Fe3O4) and the anti-cancer stem cell marker CD90 (CD90@TMs) to target and kill CD90+ liver cancer stem cells (LCSCs). METHODS: The hepatocellular carcinoma cell line Huh7 was used to separate CD90+ LCSCs by magnetic-activated cell sorting. CD90@TMs was characterized and their ability to target CD90+ LCSCs was determined. Experiments were used to investigate whether CD90@TMs combined with magnetic hyperthermia could effectively eliminate CD90+ LCSCs. RESULTS: The present study demonstrated that CD90+ LCSCs with stem cells properties were successfully isolated. We also successfully prepared CD90@TMs that was almost spherical and uniform with an average diameter of 130±4.6 nm and determined that magnetic iron oxide could be incorporated and retained a superparamagnetic response. CD90@TMs showed good targeting and increased inhibition of CD90+ LCSCs in vitro and in vivo compared to TMs. CONCLUSIONS: CD90@TMs can be used for controlled and targeted delivery of anticancer drugs, which may offer a promising alternative for HCC therapy.
|
Authors | Rui Yang, Li Y An, Qin F Miao, Feng M Li, Yong Han, Hui X Wang, Dang P Liu, Rong Chen, Sha Q Tang |
Journal | Oncotarget
(Oncotarget)
Vol. 7
Issue 24
Pg. 35894-35916
(Jun 14 2016)
ISSN: 1949-2553 [Electronic] United States |
PMID | 27145285
(Publication Type: Journal Article)
|
Chemical References |
- Antibodies
- Thy-1 Antigens
|
Topics |
- Animals
- Antibodies
(immunology, pharmacology)
- Apoptosis
(drug effects, immunology)
- Carcinoma, Hepatocellular
(drug therapy, immunology, metabolism)
- Cell Line
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Humans
- Immunomagnetic Separation
(methods)
- Liver Neoplasms
(drug therapy, immunology, metabolism)
- Mice, Inbred NOD
- Mice, SCID
- Neoplastic Stem Cells
(drug effects, immunology, metabolism)
- Temperature
- Thy-1 Antigens
(immunology, metabolism)
- Xenograft Model Antitumor Assays
(methods)
|